What You Should Know:– Glooko, a provider of remote patient monitoring and digital health solutions for diabetes, has acquired Monarch Medical Technologies, the developer of the EndoTool® Glucose Management System. – The strategic acquisition allows Glooko to expand its connected care capabilities into inpatient glycemic management, complementing its existing strength in outpatient diabetes management. The goal is to create a single, integrated solution that will support patients and clinicians across the full continuum of care. By adding Monarch Medical’s EndoTool, an FDA-cleared software platform for inpatient insulin dosing, Glooko will now support acute care settings with precision insulin dosing algorithms. The addition of Monarch Medical demonstrates how Glooko is using that capital and investor support to expand its connected care platform and solidify its position as a global leader in digital health for diabetes management.